FDA approves Boehringer’s Pradaxa
October 20, 2010Sales and Marketing Boehringer, Pradaxa, atrial fibrilation
Boehringer Ingelheim’s Pradaxa has stolen a march over its rivals by being the first new oral anticoagulant to reach the …
FDA warns of bisphosphonates fracture risk
October 20, 2010Sales and Marketing Boniva, Fosamax, Reclast, actonel, bisphosphonates, osteoporosis
The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …
NICE needs narrower focus, says ABPI
October 20, 2010Sales and Marketing ABPI, NICE, value
NICE’s remit should be changed to give it a greater focus on the value of innovation, according to UK pharma …
King’s Fund appoints Kaye Lobley to leadership post
October 20, 2010UK, appointment, king's fund
Kate Lobley will take up the post of director of leadership at health think tank The King’s Fund on 1 …
Apixaban trial for ACS abandoned
October 20, 2010Sales and Marketing ACS, BMS, Pfizer, apixaban
Pfizer and Bristol-Myers Squibb have halted a trial of their heart drug apixaban after signs of increased risk of …
Digital Pharma: NHS to lead an ‘information revolution’
October 19, 2010Medical Communications Digital Pharma blog, electronic patient records, patient information
Patients could soon be able to contact their doctor online as part of government plans for an ‘information revolution’ in …
Hill & Knowlton appoints Damaris Anderson-Supple
October 19, 2010Medical Communications Hill & Knowlton, appointment, medical communications
PR agency Hill & Knowlton has appointed Damaris Anderson-Supple to the newly created position of chief operating officer for its …
Reaxa spins out specialist antibody-drug conjugate unit
October 19, 2010Manufacturing and Production Mylotarg, Reaxa, antibody-drug conjugates
UK company Reaxa is spinning out a new company called ADC Biotechnology to develop and commercialise an improved purification technology …
NHS Confederation warns on health cuts
October 19, 2010NHS, NHS Confederation, government
In the week of the Comprehensive Spending Review, the NHS Confederation has painted a dire picture of the effect of …
Pfizer opens £26m UK packaging facility
October 19, 2010Business Services, Manufacturing and Production Pfizer, packaging, recruitment
Pfizer officially opened a new biotechnology packaging facility in Hampshire, UK, on October 15, with a ceremony attended by UK …
Dr Ben Goldacre: “This is a very broken system”
October 19, 2010Medical Communications, Research and Development, Sales and Marketing Bad Science, Ben Goldacre, industry reputation, trial data
The pharma industry has its fair share of critics, but unfortunately for everybody, many are easy to dismiss – shrill, …
GSK collaborates on rare genetic diseases
October 19, 2010Research and Development Fondazione San Raffaele, Fondazione Telethon, GlaxoSmithKline, Stem cells, gene therapy
GlaxoSmithKline has partnered with one of the biggest biomedical charities in Italy and the country’s largest private research institute to …
Bayer’s Xarelto hailed at Prix Galien
October 19, 2010Research and Development Firazyr, Xarelto, prix galien
Bayer’s Factor Xa anticoagulant Xarelto scooped the Best Pharmaceutical Agent award at the prestigious Prix Galien ceremony. Xarelto is part …
Cutting-edge cancer treatments showcased at ESMO
October 18, 2010Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine
The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …
Sanofi signs translational research deal with Harvard
October 18, 2010Research and Development Harvard, Sanofi-Aventis, academia, translational
Sanofi-Aventis is to collaborate on translational biomedical research with Harvard University in therapy areas such as cancer, diabetes and inflammation. …
Trial shows long-term benefits of Novartis’ Aclasta
October 18, 2010Research and Development, Sales and Marketing Novartis, aclasta, osteoporosis
Novartis has published new data at the annual meeting of the American Society for Bone and Mineral Research in Toronto …
27 health quangos cut or ‘reconstituted’
October 18, 2010NHS, government
The coalition government’s review of its health advisory bodies won’t end with the abolition of 10 healthcare quangos, among them …
IDEA Pharma appoints Tony Akiwumi
October 18, 2010Sales and Marketing Go-To-Market Strategy, IDEA Pharma, IDEAtion, Phase II, appointment, sales and marketing
Tony Akiwumi has joined Idea Pharma as director of client value, moving to the strategic marketing consultancy from Quintiles.He will lead …
Roche investing $180m on US diagnostics facilities
October 18, 2010Research and Development Diagnostics, Roche, Ventana, personalised medicine
Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …
In with the ‘new’: A leaner, fitter biosciences sector – 2010
October 18, 2010Sales and Marketing Kinapse, White paper
The biosciences sector has witnessed numerous challenges during recent years, as the global economic downturn has adversely impacted sector liquidity …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
